European Sero-Epidemiology Network 2: Standardisation of immunoassay results for pertussis requires homogeneity in the antigenic preparations

Vaccine

Volumn 26, Issue 35, 2008, Pages 4486-4493

  Giammanco, Anna ^a   Nardone, Antony ^b   Pebody, Richard ^b   Kafatos, George ^b   Andrews, Nick ^b   Chiarini, Alfredo ^a   Taormina, Susanna ^a   de Ory, Fernando ^c   Prosenc, Katarina ^d   Krize, Bohumir ^e   Hallander, Hans ^f   Ljungman, Margaretha ^f   Marva, Esther ^g   Tsakris, Athanassios ^h   O'Flanagan, Darina ⁱ   Schneider, François ^j   Griskevicius, Algirdas ^k   Vranckx, Robert ^l   Karacs, Ildiko ^m  

^a UNIVERSITY OF PALERMO   (Italy)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d NATIONAL INSTITUTE OF PUBLIC HEALTH   (Slovenia)

^e CHARLES UNIVERSITY   (Czech Republic)

^f SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^g Central Laboratories   (Israel)

^h UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

ⁱ HEALTH PROTECTION SURVEILLANCE CENTRE   (Ireland)

^j LABORATOIRE NATIONAL DE SANTÉ   (Luxembourg)

^k Lithuanian AIDS Centre   (Lithuania)

^l SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

^m NATIONAL CENTER FOR EPIDEMIOLOGY   (Hungary)

more..

Author keywords

ESEN (European Sero Epidemiology Network); Immunoassay standardisation; Pertussis antigenic preparations; Pertussis sero epidemiology

Indexed keywords

PERTUSSIS VACCINE;

ANTIBODY TITER; ANTIGENICITY; ARTICLE; BACTERIAL INFECTION; BORDETELLA PERTUSSIS; CLINICAL LABORATORY; ENZYME LINKED IMMUNOSORBENT ASSAY; EUROPE; IMMUNOASSAY; PERTUSSIS; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REFERENCE VALUE; SEROLOGY; STANDARD;

ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BORDETELLA PERTUSSIS; CALIBRATION; EUROPE; HUMANS; IMMUNOASSAY; PERTUSSIS VACCINE; WHOOPING COUGH;

EID: 48449088237     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.06.051     Document Type: Article

References (26)

1. Osborne K., Weinberg J., and Miller E. The European sero-epidemiology network. Eurosurveillance 2 (1997) 29-31
2. Kafatos G., Andrews N., Nardone A., and on behalf of the ESEN2 project. Model selection methodology for inter-laboratory standardisation of antibody titres. Vaccine 23 (2005) 5022-5027
3. Edmunds W.J., Pebody R..G., Aggerback H., Baron S., Berbers G., Conyn-van Spaendonck M.A.E., et al. The sero-epidemiology of diphtheria in Western Europe. Epidemiol Infect 125 (2000) 113-125
4. Pebody R.G., Edmunds W.J., Conyn-van Spaendonck M.A.E., Olin P., Berbers G., Rebiere I., et al. The seroepidemiology of rubella in Western Europe. Epidemiol Infect 125 (2000) 347-357
5. de Melker H., Pebody R.G., Edmunds W.J., Levy-Bruhl D., Valle M., Rota M.C., et al. The seroepidemiology of measles in Western Europe. Epidemiol Infect 126 (2001) 249-259
6. Nardone A., Pebody R.G., van den Hof S., Levy-Bruhl D., Plesner A.M., Rota M.C., et al. Sero-epidemiology of mumps in western Europe. Epidemiol Infect 131 (2003) 691-701
7. Pebody R.G., Andrews N., Brown D., Gopal R., de Melker H., Francois G., et al. The seroepidemiology of herpes simplex virus type 1 and 2 in Europe. Sex Transm Infect 80 (2004) 185-191
8. Nardone A., and Miller E. Serological surveillance of rubella in Europe: European Sero-Epidemiology Network (ESEN2). Eurosurveillance 9 (2004) 5-7
9. Nardone A., Pebody R.G., Maple P.A., Andrews N., Gay N.J., and Miller E. Sero-epidemiology of Bordetella pertussis in England and Wales. Vaccine 22 (2004) 1314-1319
10. Pebody R.G., Gay N.J., Giammanco A., Baron S., Schellekens J., Tischer A., et al. The seroepidemiology of Bordetella pertussis infection in Western Europe. Epidemiol Infect 133 (2005) 159-171
11. Andrews N., Pebody R.G., Berbers G., Blondeau C., Crovari P., Davidkin I., et al. The European Sero-Epidemiology Network: standardizing the enzyme immunoassay results for measles, mumps and rubella. Epidemiol Infect 125 (2000) 113-125
12. von Hunolstein C., Aggerback H., Andrews N., Berbers G., Fievet-Groyne F., Maple P.A.C., et al. European Sero-Epidemiology Network: standardisation of the results of diphtheria antitoxin assays. Vaccine 18 (2000) 3287-3296
13. de Ory F., Echevarría J.M., Kafatos G., Anastassopoulou C., Andrews N., Backhouse J., et al. European Sero-epidemiology Network 2: standardisation of assays for seroepidemiology of varicella zoster virus. J Clin Virol 36 (2006) 111-118
14. Tischer A., Andrews N., Kafatos G., Nardone A., Berbers G., Davidkin I., et al. Standardization of measles, mumps and rubella assays to enable comparisons of seroprevalence data across 21 European countries and Australia. Epidemiol Infect (2007)
15. Kafatos G., Anastassopoulou C., Nardone A., Andrews N., Barbara C., Boot H.J., et al. The European Sero-Epidemiology Network 2: standardization of assay results for hepatitis B virus. J Viral Hepat 14 (2007) 260-268
16. Giammanco A., Chiarini A., Maple P.A.C., Andrews N., Pebody R., Gay N., et al. European Sero-Epidemiology Network: standardisation of the assay results for pertussis. Vaccine 22 (2003) 112-120
17. Müller F.M., Hoppe J.E., and Wirsing-von König C.H. Laboratory diagnosis of pertussis: state of the art in 1997. J Clin Microbiol 35 (1997) 2435-2443
18. Olin P., Hallander H.O., Gustafsson L., Reizenstein E., and Storsaeter J. How to make sense of pertussis immunogenetic data. Clin Infect Dis 33 (2001) S288-S291
19. Storsaeter J., Hallander H.O., Gustafsson L., and Olin P. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine 16 (1998) 1907-1916
20. Taranger J., Trollfors B., Lagergård T., Sundh V., Bryla D.A., Schneerson R., et al. Correlation between pertussis toxin IgG antibodies in postvaccination and subsequent protection against pertussis. J Infect Dis 181 (2000) 1010-1013
21. de Melker H., Versteegh F.G.A., Conyn van Spaendonck M.A.E., Elvers L.H., van der Zee A., and Schellekens J.F.P. Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis. J Clin Microbiol 38 (2000) 800-806
22. Teunis P.F.M., Van der Heijden O.G., de Melker H.E., Schellekens J.F.P., Versteegh F.G.A., and Kretzschmar M.E.E. Kinetics of IgG antibody response to pertussis toxin after infection with B. pertussis. Epidemiol Infect 129 (2002) 479-489
23. Giuliano M., Mastrantonio P., Giammanco A., Bottone M., Piscitelli A., Di Tommaso S., et al. Antibody kinetics and long-term sero-prevalence in the Italian clinical trial of acellular pertussis vaccines. Dev Biol Stand 89 (1997) 275-278
24. Giuliano M., Mastrantonio P., Giammanco A., Piscitelli A., Salmaso S., and Wassilak S.G.F. Antibody responses and persistence in the 2 years after immunization with two acellular vaccines and one whole-cell vaccine against pertussis. J Pediatr 132 (1998) 983-988
25. Manclark C.R., Meade B.D., and Burstyn D.G. Serological responses to Bordetella pertussis. In: Rose N.R., Friedman H., and Fahey J.L. (Eds). Manual of clinical laboratory and laboratory immunology. 3rd ed. (1986), American Society for Microbiology, Washington (DC) 388-394
26. Klement E., Kagan N., Hagain L., Kayouf R., Boxman J., Cohen D., et al. Correlation of IgA, IgM and IgG antibody-detecting assays based on filamentous haemagglutinin, pertussis toxin and Bordetella pertussis sonicate in a strictly adult population. Epidemiol Infect 133 (2005) 149-158